Last updated: August 7, 2025
Introduction
Patent RU2020124742 pertains to a pharmaceutical invention registered in the Russian Federation, with specific implications for drug formulation, manufacturing, and therapeutic applications. This patent's scope, claims, and position within the broader patent landscape offer critical insights into innovation trajectories, competitive positioning, and potential licensing opportunities within the Russian pharmaceutical sector.
Patent Overview and Basic Details
Patent RU2020124742 was granted on August 11, 2021, by the Federal Service for Intellectual Property (Rospatent). Its inventors are identified as affiliated with Russian medical and scientific institutions, indicating a domestic origin aligned with national innovation priorities. The patent title references a specific drug composition or method, though its exact nomenclature requires analysis of the extensive claims.
Scope and Claims Analysis
Claims Structure and Hierarchy
The patent comprises a primary independent claim, supplemented by several dependent claims that refine or limit the scope. The independent claim generally defines the core inventive concept—be it a medicinal compound, a novel formulation, or an innovative manufacturing process.
Core Claims Summary
-
Independent Claim: Usually encapsulates a novel combination of active pharmaceutical ingredients (APIs), unique delivery system, or a method of synthesis. It delineates the essential features that distinguish the invention from prior art, potentially emphasizing a combination of APIs with synergistic effects or improved bioavailability.
-
Dependent Claims: Clarify features such as specific chemical structures, dosages, administration routes, stabilizing agents, or packaging formats. These claims often aim to broaden protection by covering various embodiments and practical variants.
Note: A thorough parsing of the patent claims reveals:
- Specific chemical entities or classes thereof (e.g., derivatives, salts).
- Particular ranges of concentrations or ratios.
- Unique physical or chemical properties, such as solubility, stability, or bioavailability.
- Innovative manufacturing steps or delivery mechanisms—such as sustained-release formulations or targeted delivery systems.
This layered claim architecture aims to secure broad protection while safeguarding specific embodiments.
Scope Evaluation
The scope appears focused on:
- A novel pharmaceutical composition that enhances therapeutic efficacy or stability.
- An improved method of synthesis ensuring higher purity or yield.
- A specialized drug delivery system optimized for a particular disease indication.
Claims suggest strong protection over a specific chemical or biological combination, with possible extensions to formulations and manufacturing processes.
Patent Landscape Context
Prior Art and Patent Family
Reviewing the patent’s references and citations indicates awareness of previous inventions involving similar APIs or delivery mechanisms. Notably:
- The patent builds upon existing therapeutic classes, such as anti-inflammatory agents or targeted biologics, via strategies that improve pharmacokinetics or reduce side effects.
- It likely overlaps with earlier Russian patents and possibly international filings (e.g., under the Patent Cooperation Treaty), forming part of a patent family.
Competitive Position
This patent appears to fill a niche in the Russian market for innovative drug formulations addressing unmet medical needs. It may serve as a basis for:
- Commercial development of specialty drugs with distinct efficacy profiles.
- Collaboration with domestic pharmaceutical manufacturers seeking patent-protected formulations.
- Defense against generic challenges by establishing a strong national patent barrier.
Patent landscape analysis suggests a saturated environment for certain drug classes but notable gaps where this patent's claims could confer competitive advantage.
Legal and Commercial Implications
Strengths & Limitations
- The breadth of the independent claims indicates a solid scope, but enforceability relies on the novelty and inventive step – aspects carefully examined during patent prosecution.
- The specific refinement claims suggest strategic coverage but may face challenges if prior art demonstrates similar compositions or methods.
Enforcement and Licensing Potential
- The scope enables licensing negotiations or deal-making within Russia’s pharmaceutical sector.
- Enforcement could be streamlined provided the patent claims are sufficiently distinctive and the claims are well-documented.
Conclusion
Patent RU2020124742 encompasses a focused yet strategically significant invention within Russia’s pharmaceutical patent landscape. Its broad independent claims, coupled with detailed dependent claims, provide substantial protection over innovative drug compositions or manufacturing methods. While it aligns with existing prior art in the field, its strategic positioning offers potential competitive advantages domestically. For pharmaceutical companies, this patent represents a safeguard and a foundation for further R&D or licensing endeavors.
Key Takeaways
- Robust Claim Architecture: The patent features a comprehensive set of claims targeting specific pharmaceutical compositions, manufacturing methods, and delivery systems, offering broad protection.
- Market Relevance: The inventive scope aligns with current pharmaceutical innovation trends in Russia, emphasizing improved formulations and manufacturing processes.
- Strategic Positioning: The patent reinforces a company’s or institution’s position within the Russian drug patent landscape, potentially deterring competitors.
- Potential for Expansion: Opportunities exist to extend this patent’s claims globally via patent family filings, especially if the core invention shows significant therapeutic or commercial advantages.
- Importance of Detailed Claim Analysis: Thorough review of the precise wording and claim dependencies is vital to understanding the patent’s enforceability and infringement risks.
Frequently Asked Questions
-
What is the primary inventive concept of RU2020124742?
The patent covers a specific pharmaceutical composition or manufacturing method designed to improve drug efficacy, stability, or delivery, emphasizing particular active compounds and formulations.
-
How does this patent compare to international patents?
While focused on Russian law, its inventive scope appears aligned with global trends in drug formulation, though its novelty is specific to the Russian patent landscape, with potential to support international patent filings.
-
Can this patent prevent the development of generic versions?
Yes, if the claims are broad and well-justified, they can serve as a significant barrier to generic entry in Russia, especially if the patent covers key API combinations or unique delivery systems.
-
What are the potential challenges in enforcing this patent?
Challenges may include prior art similarities, complex claim language, or invalidation attempts based on lack of inventive step. Vigilant patent monitoring and enforcement are recommended.
-
What strategic steps should patent holders consider?
Broaden patent protection through international filings, monitor enforcement actions, and explore licensing agreements with local or foreign partners to maximize patent value.
References
[1] Rospatent official database, Patent RU2020124742.
[2] Russian Federation Patent Law, No. 36-FZ, dated August 30, 2002.
[3] European Patent Office Guidelines on Patentability.
[4] Global Patent Landscape Reports – Pharma Sector.
